Key takeaway
ECHA’s fluorinated aliphatic hydrocarbons regulatory review has concluded with no immediate restrictions but highlights potential future policy shifts. The industry should remain vigilant about changes in classifications, hazard assessments, and exposure considerations that could impact regulatory obligations.
Currently, no new restrictions are proposed, but regulatory actions may be reconsidered if exposure risks or industrial uses change. Businesses should track ECHA’s assessments for potential updates.
These substances are widely used in fluoropolymer production, industrial cleaning, and heat transfer fluids. Companies must ensure compliance with existing EU regulations while preparing for potential future classification updates.
Source basis: https://echa.europa.eu/documents/10162/f5fbb40b-91a6-48c3-52f2-7b13bbabd518
The European Chemicals Agency (ECHA) has completed an assessment of regulatory needs for fluorinated aliphatic hydrocarbons, a group of 28 substances used in manufacturing, electronics, and industrial cleaning. Published on 7 February 2025, the review found potential hazards related to carcinogenicity, reproductive toxicity, endocrine disruption, and environmental persistence. However, no immediate EU-wide regulatory risk management measures are proposed.
The substances remain regulated under the F-Gas Regulation (EU) 2024/573 and the Ozone-Depleting Substances Regulation (EC) No 1005/2009. Industry stakeholders are advised to track potential policy developments that may impact supply chains and compliance obligations.
Fluorinated aliphatic hydrocarbons are primarily used in:
Fluoropolymer productionSemiconductor manufacturingIndustrial cleaning agentsHeat transfer and lubricant fluids
Substances such as difluoromethane (CAS: 75-10-5) and 1,1-difluoroethane (CAS: 75-37-6) have high industrial relevance, particularly in refrigerants and propellants. The study examined both saturated and unsaturated halofluorocarbons, noting their structural similarities to PFAS without classifying them as such.
ECHA’s assessment confirms that 14 substances are classified as ozone-depleting under the Montreal Protocol, meaning they are subject to phased-out production and use restrictions. Other substances fall under REACH and CLP regulations, requiring businesses to ensure proper labelling, handling, and reporting.
Although no immediate regulatory risk management (RRM) actions are proposed, the report indicates that:
Changes in reported industrial uses or exposure risks could prompt regulatory reconsiderations.Existing hazard classifications, particularly those related to endocrine disruption and persistence, may trigger new restrictions in the future.
The proposed CLP Annex VI update introduces harmonised classifications for over 100 hazardous substances, including SVHCs, PFAS and endocrine disruptors. The changes will impact labelling, safety data and product formulation across multiple sectors, requiring early compliance planning and supply chain engagement.
Bioaccumulation assessment strategies are evolving at ECHA, with practical implications for REACH and CLP evidence packages.
Upcoming PFAS restrictions and chemical reclassifications will impact manufacturing, transport, energy, medical devices, and electronics sectors.
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
